Connect with us

Medical Cannabis

How Emergency Regulations Have Put Nebraska’s Medical Cannabis Industry ‘In Limbo’

Published

on

How Emergency Regulations Have Put Nebraska’s Medical Cannabis Industry ‘In Limbo’

A month after the creation of the Nibrosk Medical Cannabis Commission The emergency rules For the young drug program, potential participants of the industry stated that they considered the rules and determined the provisions they support, and the provisions, which, they say, need work.

What they have not seen is something like an application, leaving them – as the Ogallala Hemp Dustin Krajewski farmer said, “in the suspended state”, despite 71% of voters who legalized medical cannabis last year.

“We cannot understand what to do with the application or how we can help promote the branch forward. And so it’s just unclear,” Krajewski said.

The Medical Cannabis Commission is held on Monday afternoon in Lincoln, and Krajewski hopes that it is increasingly clear. At a meeting of the commission at the end of June, Commissioner Bruce Bailey stated that he and other members had only these rules 12 hours before the vote. But they had to approve of anything to comply with the state legislation. said BaileyRules allow applicants to prepareMaterials and make sure they comply with the rules.

Read the rest of this article about Omaha World Herald, Click here

Message As the emergency rules put the medical branch of the cannabis Nebraska “in the suspension” appeared first further Retail Marijuana Retail Report – News and Information for Cannabis sellers.

(Tagstotranslate) medical cannabis (T) Nebraska

Cannabis Industry News

Investigation Deems Kentucky Medical Cannabis Licensing Process ‘Transparent and Fair’

Published

on

By

Investigation Deems Kentucky Medical Cannabis Licensing Process ‘Transparent and Fair’

The Kentucky Office of the Inspector General announced Thursday that it has concluded an investigation into the medical cannabis licensing process implemented by the state’s Office of Medical Cannabis (OMC).

“After an independent review of the program, the licensing process it established in the regulations, and related regulations and statutes, this office found that the OMC created an effective program that was fully transparent and fair to all license applicants.” – Excerpt from REPORT

The report comes a year after the OMC requested an investigation into the process.

Gov. Andy Beshear praised the program during a recent Kntucky Team Update, stating that “The Office of Medical Cannabis stated that the regulations and licensing processes were designed with two goals in mind—fairness and transparency—and the OIG report clearly acknowledged that those goals were met.” WHAS11 reports.

Meanwhile, Kentucky’s medical cannabis program began last December, serving registered patients diagnosed with conditions including cancer, chronic pain or nausea, epilepsy, multiple sclerosis or post-traumatic stress disorder (PTSD).

Based in Portland, Oregon, Graham is the editor-in-chief of Ganjapreneur. He has been writing about the legalization landscape since 2012 and has contributed to Ganjapreneur since our official launch in…

Continue Reading

cannabis policy

Texas Poll Finds 75% Support for Medical Cannabis Reforms

Published

on

By

Texas Lawmakers Will Continue Pursuing Hemp Product Restrictions In Second Special Session

A recent Texas poll found that 75% of voters support medical cannabis reforms, KTAL reports.

The survey by Fabrizio, Lee & Associates found that while three-quarters of respondents said they support the legalization of medical cannabis in general, only 11% said they had previously heard of the Texas Compassionate Use Program (TCUP), which state lawmakers passed in 2015 to grant limited access to cannabinoid-based products.

Of the 1,000 respondents, 44% said they would be more likely to vote for a legislator who supported TCUP, while only 13% said they would be less likely to vote for them.

Meanwhile, Texas lawmakers passed a new law last year expanding the TCUP to increase the number of licensed operators and allow new methods of consumption, including the distribution of vaporized or aerosolized medical cannabis, while smoking remains prohibited. The expansions also included adding traumatic brain injury, chronic pain and any terminal illness or condition requiring hospice as qualifying conditions for the program.

The poll, which was designed to gauge voter reaction to the TCUP expansions, found that 63% of Texas Republicans support legalizing medical cannabis.

Based in Portland, Oregon, Graham is the editor-in-chief of Ganjapreneur. He has been writing about the legalization landscape since 2012 and has contributed to Ganjapreneur since our official launch in…

Continue Reading

DEA

Trump Administration Moves State-Licensed Medical Marijuana to Schedule III

Published

on

By

Trump Administration Moves State-Licensed Medical Marijuana to Schedule III

The Trump administration on Thursday moved FDA-approved marijuana products and cannabis products sold under qualifying state medical marijuana licenses from Schedule I to Schedule III under federal law, while also setting a new administrative hearing for June 29, 2026 to restart and expedite the broader DEA reprogramming process.

Department of Justice said The immediate action is intended to support medical research and state-regulated medical programs while maintaining “strict federal controls against illegal drug trafficking.”

For now, the change only affects FDA-approved marijuana products and state medical marijuana markets, not adult-use cannabis businesses. This distinction is critical for the broader industry: adult-use operators are not getting immediate 280E tax relief under this order, and the measure does not provide any direct bank relief for adult-use businesses that remain federally illegal.

The administration’s announcement also indicated that the existing rescheduling process initiated by the DEA under the Biden administration would be scrapped for a new, expedited process beginning with a hearing in June. That broader process is expected to determine whether marijuana in general will be moved out of Schedule I, a question that remains especially important to adult-use operators still mired in the federal-state standoff.

“After further review, the DEA is withdrawing the prior notice of HEARING and the completion of these proceedings to move more efficiently toward the completion of the full redefinition of marijuana. This action will expedite the administrative process, include established deadlines, and allow DEA to proceed in the most expeditious manner consistent with federal law. The DEA will hold a new administrative hearing beginning June 29, 2026, regarding the proposed rescheduling of marijuana. – through the announcement of the Department of Justice

While the change represents the most significant change in federal cannabis policy in decades, even if cannabis is fully reclassified as a Schedule III substance, people currently serving time in prison for possession of cannabis will not be directly affected by the change, and businesses on the adult-use side of the industry will still be considered federally illegal.

Continue Reading
Advertisement

Trending

Copyright © 2021 The Art of MaryJane Media